advertisement

Topcon

11.14 Investigational drugs; pharmacological experiments (21)

Showing records 1 to 21

Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments

Search within classification 11.14 Investigational drugs; pharmacological experiments
19342 Effect of hypericin on retinal glutamate levels in chronic ocular hypertension rabbits
Li S; Jiang F
Chinese Ophthalmic Research 2007; 25: 370-372
19246 Hypotensive effect of profilin on rabbit intraocular pressure
Morales M; Gomez-Cabrero A; Peral A; Gasull X; Pintor J
European Journal of Pharmacology 2007; 567: 145-148
19295 Survival and axonal regeneration of off-center retinal ganglion cells of adult cats are promoted with an anti-glaucoma drug, nipradilol, but not BDNF and CNTF
Yata T; Nakamura M; Sagawa H; Tokita Y; Terasaki H; Watanabe M
Neuroscience 2007; 148: 53-64
19523 Effects of dopamine on retinal and choroidal blood flow parameters in humans
Huemer KH; Zawinka C; Garhöfer G; Golestani E; Litschauer B; Dorner GT; Schmetterer L
British Journal of Ophthalmology 2007; 91: 1194-1198
19413 The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents
Mincione F; Scozzafava A; Supuran CT
Current Topics in Medicinal Chemistry 2007; 7: 849-854
19476 Clinical evaluation of the neuroprotective effect of alpha-tocopherol against glaucomatous damage
Engin KN; Engin G; Kucuksahin H; Oncu M; Guvener B
European Journal of Ophthalmology 2007; 17: 528-533
19343 Effect of nerve regeneration factor on expression of inducible-nitric oxide synthase in retina with experimental intraocular hypertension
Guan H; Huang Z; Ding F; Gu X
Chinese Ophthalmic Research 2007; 25: 325-328
19383 Pathologically-activated therapeutics for neuroprotection: Mechanism of NMDA receptor block by memantine and S-nitrosylation
Lipton SA
Current Drug Targets 2007; 8: 621-632
19266 Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders
Lipton SA; Gu Z; Nakamura T
International review of neurobiology 2007; 82: 1-27
19557 Erythropoietin: A candidate neuroprotective agent in the treatment of glaucoma
Tsai JC; Song BJ; Wu L; Forbes M
Journal of Glaucoma 2007; 16: 567-571
19392 Fixed-combination and emerging glaucoma therapies
Woodward DF; Chen J
Expert Opinion on Emerging Drugs 2007; 12: 313-327
19341 Effects of low dose of latrunculin-A on actin cytoskeleton and extracellular matrix protein TSP-1 in dexamethasone-induced bovine TMCs
Cao J; Zhang D
Chinese Ophthalmic Research 2007; 25: 502-505
19424 Research progress on application of ET-1 on eyes
Cao W-J; Zhou Y-H
International Journal of Ophthalmology 2007; 7: 782-783
19333 Novel benzodifuran analogs as potent 5-HT(2A) receptor agonists with ocular hypotensive activity
Feng Z; Mohapatra S; Klimko PG; Hellberg MR; May JA; Kelly C; Williams G; McLaughlin MA; Sharif NA
Bioorganic and Medicinal Chemistry Letters 2007; 17: 2998-3002
19421 The protective function of erythropoietin to the rat retina after acute intraocular hypertension
Guo Y; Wang W-H
International Journal of Ophthalmology 2007; 7: 688-691
19431 Protective effect on visual functions of long-term use of trimetazidine in treatment of primary open angle glaucoma and degenerative myopia
Nowak MS; Wybor K; Gos R; Zeman-Miecznik A; Waszczykowska A; Pastuszka M; Klysik A; Gajdowska A
Archives of Medical Science 2007; 3: 152-156
19359 Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits
Privitera MG; Potenza M; Bucolo C; Leggio GM; Drago F
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 232-239
19376 Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma
Rao VP; Epstein DL
BioDrugs 2007; 21: 167-177
19434 Therapeutic potential of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the treatment of retinal and eye diseases
Schmeer C; Kretz A; Isenmann S
CNS and Neurological Disorders - Drug Targets 2007; 6: 282-287
19634 Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys
Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
Investigative Ophthalmology and Visual Science 2007; 48: 3216-3222
19411 Metal binding functions in the design of carbonic anhydrase inhibitors
Winum J-Y; Scozzafava A; Montero J-L; Supuran CT
Current Topics in Medicinal Chemistry 2007; 7: 835-848

Issue 9-3

Change Issue


advertisement

Oculus